Vendeur
Romtrade Corp., STERLING HEIGHTS, MI, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Vendeur AbeBooks depuis 17 avril 2013
This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. N° de réf. du vendeur ABNR-245428
The most comprehensive, current sickle cell disease resource--for both clinicians and researchers
A Doody's Core Title for 2024 & 2023!
The first and only resource of its kind, Sickle Cell Disease examines this blood disorder through both clinical and research lenses. More than 80 dedicated experts in the field present their combined clinical knowledge of basic mechanisms, screening, diagnosis, management, and treatment of myriad complex complications of a single base point mutation in the human genome. Case studies with "How I Treat" authoritative insights provide overviews of common and rare complications, and Key Facts offer at-a-glance high-yield information.
Filled with clinical photos, illustrations, numerous original diagrams, and with free updates available online, this unmatched resource covers:
À propos de l?auteur:
Mark T. Gladwin, MD, is Professor and Chairman, Department of Medicine, University of Pittsburgh, and Director, Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute.
Gregory J. Kato, MD, is Professor of Medicine, Division of Hematology/Oncology, University of Pittsburgh, and Director, University of Pittsburgh's Sickle Cell Center of Excellence.
Enrico M. Novelli, MD, is Associate Professor of Medicine, Division of Hematology/Oncology, University of Pittsburgh, and Director, University of Pittsburgh Medical Center's Adult Sickle Cell Disease Program.
Titre : SICKLE CELL DISEASE (HB 2021)
Éditeur : McGraw Hill / Medical
Date d'édition : 2021
Reliure : Couverture rigide
Etat : New